BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, December 31, 2025
See today's BioWorld
Home
» Other news to note for March 4, 2021
To read the full article
sign up for free
or
sign in
.
Other news to note for March 4, 2021
March 4, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Akari, Aptamer, Arch, Astrazeneca, Autifony, Bellicum, Biogen, Boehringer, Claritas, Conserv, Curevac, Dicerna, Etherna, Foresee, Intas, GC, Hookipa, Juvenescence, Lipocine, Lumos, Merck, Mitsubishi Tanabe, Moderna, Novartis, Oncology Pharma, Pandion, Portage, Roche Silo, Sunshine, Therapeutic Solutions, Tonix.
BioWorld
Briefs
Other news to note
Coronavirus